Patents by Inventor Frederick W. Jacobsen

Frederick W. Jacobsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8734796
    Abstract: Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: May 27, 2014
    Assignee: Amgen Inc.
    Inventors: Kenneth W. Walker, Yue-Sheng Li, Thomas C. Boone, Frederick W. Jacobsen, HoSung Min, Jane Talvenheimo, Taruna Arora, Janet Doellgast
  • Publication number: 20130209475
    Abstract: The present invention provides antibodies and immunologically functional fragments thereof that specifically bind DKK1 polypeptides. Methods for preparing such antibodies or fragments thereof as well as physiologically acceptable compositions containing the antibodies or fragments are also provided. Use of the antibodies and fragments to treat various diseases are also disclosed.
    Type: Application
    Filed: October 27, 2011
    Publication date: August 15, 2013
    Inventors: William Gleason Richards, Hsieng Sen Lu, Hua Zhu Ke, Chaoyang Li, Frederick W. Jacobsen
  • Publication number: 20130189283
    Abstract: Disclosed is an isolated immunoglobulin. Also disclosed are pharmaceutical compositions and medicaments comprising the immunoglobulin, isolated nucleic acid encoding it, vectors, host cells, useful in methods of making it. In some embodiments the immunoglobulin comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.
    Type: Application
    Filed: September 22, 2011
    Publication date: July 25, 2013
    Applicant: AMGEN INC.
    Inventors: Kenneth W. Walker, Frederick W. Jacobsen, Taruna Arora
  • Patent number: 8454962
    Abstract: There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: June 4, 2013
    Assignee: Amgen Inc.
    Inventors: Hailing Hsu, Ian Foltz, Taruna Arora, Frederick W. Jacobsen
  • Patent number: 8454961
    Abstract: There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: June 4, 2013
    Assignee: Amgen Inc.
    Inventors: Hailing Hsu, Ian Foltz, Taruna Arora, Frederick W. Jacobsen
  • Patent number: 8444981
    Abstract: There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: May 21, 2013
    Assignee: Amgen Inc.
    Inventors: Hailing Hsu, Ian Foltz, Taruna Arora, Frederick W. Jacobsen
  • Patent number: 8414893
    Abstract: Compositions for treating neurodegenerative or amyloidogenic disorders such as Alzheimer's disease (AD) are provided. More particularly, anti-amyloid-beta antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: April 9, 2013
    Assignee: Amgen Inc.
    Inventors: Anja Leona Biere-Citron, Frederick W. Jacobsen, Stephen J. Wood
  • Publication number: 20120195879
    Abstract: Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.
    Type: Application
    Filed: March 19, 2010
    Publication date: August 2, 2012
    Applicant: Amgen Inc.
    Inventors: Kenneth W. Walker, Yue-Sheng Li, Thomas C. Boone, Frederick W. Jacobsen, HoSung Min, Jane Talvenheimo, Taruna Arora, George Doellgast, Janet Doellgast
  • Publication number: 20120183561
    Abstract: There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 19, 2012
    Applicant: Amgen Inc.
    Inventors: Hailing HSU, Ian Foltz, Taruna Arora, Frederick W. Jacobsen
  • Publication number: 20120177662
    Abstract: There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 12, 2012
    Applicant: Amgen Inc.
    Inventors: Hailing HSU, Ian Foltz, Taruna Arora, Frederick W. Jacobsen
  • Publication number: 20120121591
    Abstract: Disclosed are compositions of matter having an amino acid sequence of SEQ ID NO:4, or a pharmaceutically acceptable salt thereof, including embodiments comprising a toxin peptide analog related to ShK, HmK, and AETX-K and pharmaceutical compositions or medicaments containing them along with a pharmaceutically acceptable carrier. Some embodiments include a half-life extending moiety. Also disclosed are a method of preventing or mitigating a relapse of a symptom of multiple sclerosis and a method of treating an autoimmune disorder using the compositions.
    Type: Application
    Filed: March 19, 2010
    Publication date: May 17, 2012
    Applicant: Amgen Inc.
    Inventors: John K. Sullivan, Leslie P. Miranda, Colin V. Gegg, Shaw-Fen Sylvia Hu, Edward J. Belouski, Justin K. Murray, Hung Nguyen, Kenneth W. Walker, Taruna Arora, Frederick W. Jacobsen, Yue-Sheng Li, Thomas C. Boone
  • Publication number: 20110044986
    Abstract: Compositions for treating neurodegenerative or amyloidogenic disorders such as Alzheimer's disease (AD) are provided. More particularly, anti-amyloid-beta antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
    Type: Application
    Filed: December 19, 2008
    Publication date: February 24, 2011
    Applicant: Amgen Inc.
    Inventors: Anja Leona Biere-Citron, Frederick W. Jacobsen, Stephen J. Wood
  • Publication number: 20100254975
    Abstract: There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: March 16, 2010
    Publication date: October 7, 2010
    Applicant: Amgen Inc.
    Inventors: Hailing Hsu, Ian Foltz, Taruna Arora, Frederick W. Jacobsen
  • Patent number: 4355780
    Abstract: A device for floatably supporting a portion of a heat exchanger core to a shell for accommodating thermal expansion.
    Type: Grant
    Filed: March 17, 1980
    Date of Patent: October 26, 1982
    Assignee: The Garrett Corporation
    Inventors: David G. Bridgnell, Frederick W. Jacobsen
  • Patent number: 4216937
    Abstract: A device for floatably supporting a portion of a heat exchanger core to a shell for accommodating thermal expansion while damping oscillatory movement of the core.
    Type: Grant
    Filed: July 18, 1975
    Date of Patent: August 12, 1980
    Assignee: The Garrett Corporation
    Inventors: David G. Bridgnell, Frederick W. Jacobsen